抗人CD19抗体（克隆号SJ25C1）引用文献

抗人CD19单克隆抗体（克隆号SJ25C1）引用文献如下：

1. CD19 CAR antigen engagement mechanisms and affinity tuning
2. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
3. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
4.HLA-independent T cell receptors for targeting tumors with low antigen density
5.The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies
6.Tuning the Antigen Density Requirement for CAR T Cell Activity
7.Unraveling resistance mechanisms in anti-CD19 chimeric antigen receptor-T therapy for B-ALL: a novel in vitro model and insights into target antigen dynamics
8.Single-cell analyses identify brain mural cells expressing CD19 as potential off-tumor targets for CAR-T immunotherapies
9.PPARδ inhibition blocks the induction and function of tumor-induced IL-10+ regulatory B cells and enhances cancer immunotherapy
10.Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging
11.Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child
12.
Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
13.The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1+ regulator B cells mediates immunosuppression in triple-negative breast cancer
14.A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
15.Engineered CD47 protects T cells for enhanced antitumour immunity
16.Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12
17.Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy
18.Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
19.Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
20.Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence
……

Syd Labs抗人CD19重组抗体（克隆号SJ25C1）：

Syd Labs 重组抗人CD19单克隆抗体（克隆号SJ25C1），小鼠IgG1 Kappa，体内实验级（In vivo Grade Recombinant Anti-human CD19 Monoclonal Antibody (Clone: SJ25C1), Mouse IgG1 Kappa, 货号：PA007270.m1）是用哺乳动物细胞生产的重组抗体，可用于ELISA，流式细胞术（FC），中和（neutralization），功能测定如生物分析 PK 和 ADA 测定，以及那些用于研究受人 CD19蛋白影响的生物学途径的测定。

如果需要了解更多有关Syd Labs 重组抗人CD19抗体(克隆号SJ25C1)信息，比如Syd Labs 抗人CD19抗体使用说明等资料，欢迎联系多找找获取。

特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。